Genetic Studies of POAG in Ghana, West Africa

西非加纳的 POAG 遗传学研究

基本信息

  • 批准号:
    6676243
  • 负责人:
  • 金额:
    $ 15.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-09-30 至 2006-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Primary Open Angle Glaucoma (POAG) is the leading cause of blindness among African Americans living in the United States. Within this patient population, it has a prevalence that is 4-6 times greater, clinically more severe, and more likely to lead to blindness than in white Americans. The objective of this research is to determine the genetic basis of this complex inherited disease. With this vital information, future methods of diagnosis, treatment and possible prevention will be elucidated. POAG is highly prevalent and is a leading cause of blindness in West Africa. A large portion of the African American population living in the United States has its origins in West Africa. The study of genetics of POAG in the West African population offers several advantages to similar studies being conducted in the United States. Glaucoma is highly prevalent in West Africa and POAG is the dominant form. Families are larger in West Africa are mobile. These qualities greatly assist identifying and then locating families and family members that meet study criteria. Disease phenotype is generally more severe, at least in part due to shortages in health care delivery. Therefore, families with multiple affected members are more common, a critical element for any genetic study. Finally, the populations on West Africa are more homogeneous than similar populations in the U.S. and elsewhere. There has been very little population emigration to Ghana or West Africa thus resulting in reduced genetic admixture. Genetic admixture is very common in the U.S. and elsewhere. This is very important since greater genetic homogeneity increases the power to detect and identify genetic sources of inherited diseases. The specific aims of this study are to 1) screen glaucoma patient populations in Ghana, West Africa and identify 150 discordant sib pairs with POAG and 2) create a West African POAG clinical and DNA association dataset to evaluate current and future candidate loci for POAG. Candidate genes within regions that demonstrate association will be screened using SNP and gene sequencing strategies. The clinical and genetic dataset created by proposal will be invaluable for future investigations of glaucoma in this population. This dataset can also serve as a foundation for genetic linkage dataset for genome-wide screen to identify new candidate genes and loci in this important population.
描述(由申请人提供):原发性开角型青光眼(POAG)是生活在美国的非洲裔美国人失明的主要原因。在该患者人群中,其患病率是白色美国人的4-6倍,临床上更严重,更可能导致失明。这项研究的目的是确定这种复杂的遗传性疾病的遗传基础。 有了这些重要的信息,未来的诊断,治疗和可能的预防方法将得到阐明。开角型青光眼在西非非常普遍,是致盲的主要原因。 生活在美国的非洲裔美国人中有很大一部分来自西非。在西非人群中进行的POAG遗传学研究为在美国进行的类似研究提供了几个优势。 青光眼在西非高度流行,而开角型青光眼是主要形式。 西非的家庭规模较大,是移动的。这些品质极大地帮助识别和定位符合研究标准的家庭和家庭成员。 疾病表型通常更严重,至少部分原因是医疗服务短缺。因此,有多个受影响成员的家庭更常见,这是任何遗传研究的关键因素。 最后,西非的人口比美国和其他地方的类似人口更加同质化。 很少有人口移民到加纳或西非,从而减少了遗传混合。 基因混合在美国和其他地方很常见。 这是非常重要的,因为更大的遗传同质性增加了检测和识别遗传性疾病遗传来源的能力。本研究的具体目的是:1)筛选西非加纳的青光眼患者人群,并确定150个POAG不一致的同胞对; 2)创建西非POAG临床和DNA关联数据集,以评估POAG当前和未来的候选基因座。 将使用SNP和基因测序策略筛选证明相关性的区域内的候选基因。该提案创建的临床和遗传数据集将对该人群的青光眼未来研究非常宝贵。 该数据集也可以作为遗传连锁数据集的基础,用于全基因组筛选,以在这个重要的群体中识别新的候选基因和位点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert RAND ALLINGHAM其他文献

Robert RAND ALLINGHAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert RAND ALLINGHAM', 18)}}的其他基金

Gene Discovery in Primary Congenital Glaucoma
原发性先天性青光眼的基因发现
  • 批准号:
    8925892
  • 财政年份:
    2013
  • 资助金额:
    $ 15.4万
  • 项目类别:
Gene Discovery in Primary Congenital Glaucoma
原发性先天性青光眼的基因发现
  • 批准号:
    8562510
  • 财政年份:
    2013
  • 资助金额:
    $ 15.4万
  • 项目类别:
Gene Discovery in Primary Congenital Glaucoma
原发性先天性青光眼的基因发现
  • 批准号:
    8712499
  • 财政年份:
    2013
  • 资助金额:
    $ 15.4万
  • 项目类别:
Genomic Convergence in Primary Open Angle Glaucoma
原发性开角型青光眼的基因组趋同
  • 批准号:
    7171787
  • 财政年份:
    2004
  • 资助金额:
    $ 15.4万
  • 项目类别:
Genomic Convergence in Primary Open Angle Glaucoma
原发性开角型青光眼的基因组趋同
  • 批准号:
    7342815
  • 财政年份:
    2004
  • 资助金额:
    $ 15.4万
  • 项目类别:
Genomic Convergence in Primary Open Angle Glaucoma
原发性开角型青光眼的基因组趋同
  • 批准号:
    7544450
  • 财政年份:
    2004
  • 资助金额:
    $ 15.4万
  • 项目类别:
Genomic Convergence in Primary Open Angle Glaucoma
原发性开角型青光眼的基因组趋同
  • 批准号:
    6983393
  • 财政年份:
    2004
  • 资助金额:
    $ 15.4万
  • 项目类别:
Genomic Convergence in Primary Open Angle Glaucoma
原发性开角型青光眼的基因组趋同
  • 批准号:
    6870353
  • 财政年份:
    2004
  • 资助金额:
    $ 15.4万
  • 项目类别:
Genetic Studies of POAG in Ghana, West Africa
西非加纳的 POAG 遗传学研究
  • 批准号:
    6927876
  • 财政年份:
    2003
  • 资助金额:
    $ 15.4万
  • 项目类别:
Genetic Studies of POAG in Ghana, West Africa
西非加纳的 POAG 遗传学研究
  • 批准号:
    6804091
  • 财政年份:
    2003
  • 资助金额:
    $ 15.4万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.4万
  • 项目类别:
    Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 15.4万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 15.4万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 15.4万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 15.4万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 15.4万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 15.4万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 15.4万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 15.4万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 15.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了